Placeholder

C-Suite: CROs

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

CROs: Integrated Outsourcing Growth Opportunities Ahead

The global R&D outsourcing market by 2018 is expected to be 37.1% of the total pharmaceutical R&D expenditure compared with 25.3% in 2010.

In GBI Research’s latest report, Contract Research Organizations (CROs) Market to 2018 — Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs, analysts say the global R&D outsourcing market is expected to increase by 5% a year until 2018. All companies are looking to cut down the time for launch of drugs along with a reduction in the…

FEEDBACK